Company profile for Eccogene

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. The company focuses on discovery and development of translational medicine in metabolic and immune-related diseases. Eccogene is specialized in disease biology, medicinal chemistry, and translational science to advance its novel and differentiated pipeline of drugs to addr...
Eccogene is a clinical stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet medical needs globally. The company focuses on discovery and development of translational medicine in metabolic and immune-related diseases. Eccogene is specialized in disease biology, medicinal chemistry, and translational science to advance its novel and differentiated pipeline of drugs to address the unmet medical needs for metabolic and immune-related diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Room 402A, No. 326, Edison Road, Pudong New District, Shanghai, China
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/06/3161592/0/en/Eccogene-Receives-U-S-FDA-Clearance-to-Initiate-Phase-2a-MOSAIC-Trial-of-ECC4703-and-ECC0509-for-MASH.html

GLOBENEWSWIRE
06 Oct 2025

https://www.globenewswire.com/news-release/2025/06/18/3101325/0/en/Eccogene-Announces-First-Patient-Dosed-in-Phase-1b-Trial-of-AZD5004-ECC5004-a-Novel-Oral-GLP-1-Receptor-Agonist-in-China.html

GLOBENEWSWIRE
18 Jun 2025

https://www.globenewswire.com/news-release/2025/06/17/3100531/0/en/Eccogene-to-Report-Preclinical-Data-with-ECC4703-Showcasing-Impact-on-Lean-Muscle-Sparing-and-Fat-Loss-in-Combination-with-Semaglutide-and-Tirzepatide.html

GLOBENEWSWIRE
17 Jun 2025

https://www.globenewswire.com/news-release/2025/05/01/3072242/0/en/Eccogene-Appoints-Dr-Jai-Patel-as-Chief-Medical-Officer.html

GLOBENEWSWIRE
01 May 2025

https://www.globenewswire.com/news-release/2025/01/07/3005228/0/en/Eccogene-Announces-Formation-of-Scientific-Advisory-Board.html

GLOBENEWSWIRE
07 Jan 2025

https://www.globenewswire.com/news-release/2024/11/15/2982129/0/en/Eccogene-Announces-Positive-Phase-1-Data-for-Oral-THR-%CE%B2-Full-Agonist-and-Oral-SSAO-Inhibitor-in-Late-Breaking-Poster-Presentations-at-the-American-Association-for-the-Study-of-Live.html

GLOBENEWSWIRE
15 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty